Trimas Corp TRS
We take great care to ensure that the data presented and summarized in this overview for TRIMAS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TRS
View all-
Vanguard Group Inc Valley Forge, PA3.81MShares$98.1 Million0.0% of portfolio
-
Fiduciary Management Inc Milwaukee, WI3.19MShares$82.1 Million0.77% of portfolio
-
Allspring Global Investments Holdings, LLC3.15MShares$80.9 Million0.13% of portfolio
-
Black Rock Inc. New York, NY3.13MShares$80.6 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$67.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$66.3 Million0.02% of portfolio
-
Richard Pzena Pzena Investment Management LLC2.14MShares$55.1 Million0.18% of portfolio
-
Bank Of America Corp Charlotte, NC1.55MShares$39.8 Million0.0% of portfolio
-
River Road Asset Management, LLC1.46MShares$37.4 Million0.52% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.13MShares$29.1 Million0.18% of portfolio
Latest Institutional Activity in TRS
Top Purchases
Top Sells
About TRS
TriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
Insider Transactions at TRS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 19
2024
|
Scott A Mell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-6.56%
|
$50,000
$25.94 P/Share
|
Nov 15
2024
|
Thomas A Amato President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.96%
|
$250,000
$25.83 P/Share
|
Nov 11
2024
|
Daniel P Tredwell Director |
BUY
Open market or private purchase
|
Direct |
79
+0.15%
|
$2,133
$27.51 P/Share
|
Oct 08
2024
|
Teresa M. Finley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,146
+2.87%
|
$28,650
$25.08 P/Share
|
Aug 12
2024
|
Daniel P Tredwell Director |
BUY
Open market or private purchase
|
Direct |
91
+0.18%
|
$2,093
$23.71 P/Share
|
Jul 09
2024
|
Teresa M. Finley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,168
+3.01%
|
$28,032
$24.61 P/Share
|
Jul 01
2024
|
Scott A Mell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,417
-4.44%
|
$35,425
$25.13 P/Share
|
May 21
2024
|
Scott A Mell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,500
-4.49%
|
$40,500
$27.3 P/Share
|
May 10
2024
|
Daniel P Tredwell Director |
BUY
Open market or private purchase
|
Direct |
80
+0.16%
|
$2,080
$26.8 P/Share
|
May 08
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
6,000
+10.5%
|
$156,000
$26.27 P/Share
|
May 07
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
6,000
+11.73%
|
$156,000
$26.01 P/Share
|
May 06
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
6,100
+13.48%
|
$158,600
$26.52 P/Share
|
May 03
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
1,500
+4.34%
|
$39,000
$26.34 P/Share
|
May 02
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
1,500
+4.54%
|
$39,000
$26.31 P/Share
|
May 01
2024
|
Herbert K Parker Director |
BUY
Open market or private purchase
|
Direct |
1,000
+3.22%
|
$25,000
$25.98 P/Share
|
May 01
2024
|
Jeffrey M Greene Director |
SELL
Open market or private sale
|
Direct |
4,000
-19.52%
|
$104,000
$26.01 P/Share
|
Apr 09
2024
|
Teresa M. Finley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,096
+2.92%
|
$28,496
$26.23 P/Share
|
Mar 14
2024
|
Jodi F. Robin General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,628
+24.87%
|
-
|
Mar 14
2024
|
Scott A Mell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,239
+29.88%
|
-
|
Mar 14
2024
|
Jeffrey A Fielkow Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,068
+32.33%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 116K shares |
---|---|
Open market or private purchase | 43.4K shares |
Payment of exercise price or tax liability | 26.6K shares |
---|---|
Open market or private sale | 11K shares |